Health Care [ 9/12 ] | Health Care Providers & Services [ 65/73 ]
NASDAQ | Common Stock
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus.
The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin).
In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names.
Other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag to promote peaceful sleep; Otikon ear drops, which is a Class II medical device in the form of ear drops; and Bio-bebe, an organic infant care and nutrition brand.
The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies, and independent specialty distributors.
Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Apr 15, 25 | -0.41 Increased by +75.86% | -0.08 Decreased by -412.50% |
| Nov 18, 24 | -0.45 Decreased by -68.35% | -0.11 Decreased by -309.09% |
| Aug 19, 24 | -0.15 Decreased by -65.38% | -0.14 Decreased by -7.14% |
| Apr 12, 24 | -0.11 Increased by +98.54% | -0.14 Increased by +21.43% |
| Dec 31, 23 | -1.70 Increased by +55.50% | -0.20 Decreased by -749.10% |
| Nov 20, 23 | -0.27 Decreased by -234.12% | - |
| Aug 15, 23 | -0.09 Increased by +90.25% | - |
| May 16, 23 | -7.51 Decreased by -1.34 K% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 25 | 13.71 M Decreased by -5.98% | -818.10 K Increased by +56.17% | Decreased by -5.97% Increased by +53.39% |
| Dec 31, 24 | 14.22 M Decreased by -10.20% | -9.54 M Increased by +30.61% | Decreased by -67.09% Increased by +22.72% |
| Sep 30, 24 | 12.41 M Decreased by -3.22% | -2.18 M Increased by +34.83% | Decreased by -17.59% Increased by +32.67% |
| Jun 30, 24 | 13.21 M Increased by +6.82% | -2.59 M Decreased by -163.95% | Decreased by -19.62% Decreased by -147.09% |
| Mar 31, 24 | 14.58 M Increased by +18.10% | -1.87 M Decreased by -305.92% | Decreased by -12.80% Decreased by -243.73% |
| Dec 31, 23 | 15.84 M Increased by +31.44% | -13.75 M Decreased by -27.10% | Decreased by -86.82% Increased by +3.30% |
| Sep 30, 23 | 12.82 M Increased by +6.72% | -3.35 M Decreased by -69.77% | Decreased by -26.12% Decreased by -59.08% |
| Jun 30, 23 | 12.36 M Decreased by -6.40% | -981.53 K Increased by +20.92% | Decreased by -7.94% Increased by +15.52% |